Rifampicin-induced urticaria in leprosy

Leprosy Review

Volumn 68, Issue 4, 1997, Pages 331-332

  Sharma, Vinod K ^a   Kaur, Inderjeet ^a   Vatve, Maneesha ^a   Kumar, Bhushan ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; CLOFAZIMINE; DAPSONE; HEMOGLOBIN; LEPROSTATIC AGENT; OFLOXACIN; PREDNISOLONE; RIFAMPICIN;

ADULT; ARTICLE; CASE REPORT; DISEASE SEVERITY; DRUG WITHDRAWAL; FEMALE; HUMAN; INDIA; LEPROMATOUS LEPROSY; PATCH TEST; PRICK TEST; PRURITUS; SKIN BIOPSY; URTICARIA;

EID: 0031457611     PISSN: 03057518     EISSN: None     Source Type: Journal    
DOI: 10.5935/0305-7518.19970041     Document Type: Article

References (10)

1. Poole G, Stradling P, Worlledge S. Potentially serious side effects of high dose high dose twice weekly rifampicin. Brit. Med. J. 1971; 3: 343-347.
2. Aquinas SM, Allan WGL, Horsfall Pal, Jenkins PK, Hung-Yan W, Girgling D, Tall R, Fox W. Adverse reactions to daily and intermittent regimes for pulmonary tuberculosis in Hong Kong. Brit. Med. J. 1972; 1: 765-771.
3. Dhar S, Kaur I, Sharma VK, Kumar B. Flu syndrome due to rifampicin: experience of 4 cases. Int. J. Lepr. 1995; 63: 92-94.
4. Jopling WH. Reference to side-effects of antileprosy drugs in common use. Lepr. Rev. 1985; 56: 61-70.
5. Vijaykumaran P, Manimozhi N, Jesudasan K, Arunthatni S, Jacob M, Samuel P. Leucocytopenia and rifampicin and ofloxacin therapy in leprosy. Lepr. Rev. 1997; 68: 10-15.
6. Sule RR. An unusual reaction to rifampicin once monthly dose. Lepr. Rev. 1996; 67: 227-228.
7. Harland RW, Lindblom SS. Anaphylaxis from rifampicin. Am. J. Med. 1992; 92: 581-582.
8. Nessi R, Domenichini E, Fowst G. "Allergic" reactions to rifampicin treatment: a review of published cases. Scand. J. Respir. Dis. 1973; 84 (suppl): 15-19.
9. Wurtz RR, Abrams D, Becker S, Jacobson MA, Mass M, Marks SM. Anaphylactoid drug reaction to ciprofloxacin and rifampicin in HIV infected patients. Lancet 1989; 1: 955-956.
10. Brasil MTLRF, Opromolla DVA, Marzilak MLC, Nogueira W. Result of surveillance system of adverse effects in leprosy's WHO/MDT. Int. J. Lepr. 1996; 64: 97-104.